-

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

Single unit provides insufflation, smoke evacuation, and desufflation, with options for heated and humidified gas

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +.

The ENDOFLATOR + insufflator represents a significant leap forward, combining high flowrates with integrated smoke removal.

Share

ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms.

Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparoscopic and robotic procedures, providing surgeons with the necessary space to operate. When paired with smoke evacuation, the insufflator is designed to preserve image clarity by removing surgical smoke and particulates, improving visibility and allowing for enhanced surgical precision.

The ENDOFLATOR + represents a significant leap forward, offering high flowrates and an ULPA filter that helps maintain a smoke-free image, improving visibility and maneuverability while reducing harmful surgical smoke. Specific features include:

  • CO₂ insufflation up to 50 L/min
  • Integrated smoke evacuation in HF and continuous modes
  • Four procedural modes: high-flow, pediatric, taTME, and EVH
  • Heated and humidified gas delivery with proprietary tubing sets
  • RFID-enabled tubing for simplicity and safety

The system is engineered to support procedures across various specialties—general surgery, cardiovascular surgery, colorectal surgery, gynecology, pediatric surgery*, proctology, and urology—in both conventional laparoscopic and robotic settings.

“This launch marks a major milestone for KARL STORZ and the healthcare providers we serve,” said Fernando Morales, Vice President, Surgical & OR Integration. “The ENDOFLATOR + not only meets high standards of safety and performance but also aligns with new surgical smoke evacuation mandates across multiple states.”

The ENDOFLATOR + and its five proprietary tubing sets are now available for order. Customers are encouraged to contact their KARL STORZ representative for demos, pricing, and promotional offers.

*cleared for patients aged 2 and up

About KARL STORZ

KARL STORZ is an innovative leader in endoscopic technology and surgical imaging solutions across virtually all surgical specialties. Its integrated OR solutions, including advancements in digital surgery, enhance collaboration to improve clinical efficiency and outcomes inside the hospital and across other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit www.karlstorz.com.

Contacts

Media contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
657-385-5285

KARL STORZ


Release Versions

Contacts

Media contact:
Susan Mancia
Marketing Communications
KARL STORZ United States
657-385-5285

Social Media Profiles
More News From KARL STORZ

KARL STORZ Expands Its Robotics Ecosystem Through Strategic Partnerships in the US

TUTTLINGEN, Germany--(BUSINESS WIRE)--Through new strategic partnerships across the robotics ecosystem in the United States, the family-owned MedTech company KARL STORZ is bringing together advanced 3D visualization, robotic technologies, digital capabilities, and operating room integration. The collaborations with Moon Surgical and Sovato support a more open and connected approach to surgical innovation, designed to expand access, improve workflow efficiency, and enable future models of surgic...

KARL STORZ Announces FDA Clearance for Rubina Lens for Open Surgery

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the Rubina™ Lens exoscope for open surgery, broadening the company’s near-infrared (NIR) imaging ecosystem across open and minimally invasive procedures in the United States. The digital, camera‑based Rubina™ Lens exoscope displays a real‑time, magnified 4K image of the surgical field on a monitor. With the ability to switch into NIR imaging u...

KARL STORZ Receives FDA Clearance for FIVE S 6.5 Bronchoscope

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in endoscopic and minimally invasive surgical technology, has received FDA clearance for the FIVE S 6.5 sterile single-use bronchoscope. The device offers a valuable new option for critical care physicians, intensivists, RTs, and ICU-based proceduralists seeking airway control solutions for high-risk patients—especially those managing heavy secretions or in urgent situations requiring fast airway clearance. “The FIVE S 6.5 single-...
Back to Newsroom